The plan was to pool savings and reallocate the money to priority medicines and markets for Britain's biggest drugmaker, according to sources familiar with the matter. » Read More
By: Angelica LaVito
Since President Trump took office, drugmakers have hiked list prices on hundreds of drugs at rates that outpace inflation, Axios reports. » Read More
New HHS secretary: Opioid addiction is not a moral failing and should be treated as a medical condition
Opioid-dependent people are "individuals who are getting trapped in a cycle of addiction," HHS' Alex Azar argues. » Read More
By: Angelica LaVito
Johnson & Johnson Chief Financial Officer Dominic Caruso plans to retire in September, the company said Tuesday. » Read More
The temporary expansion of this deduction means more taxpayers could benefit on their 2017 and 2018 returns.
Saturday Night Live did a skit last year on Amazon partnering with the AARP to create Alexa for elderly people. Turns out the skit may come true.
Scientists are studying what happens to humans in the microgravity of outer space to learn more about aging and other diseases.
The Food and Drug Administration is taking the first step toward implementing a rule about the role flavors, including menthol, play in attracting users to certain tobacco products.
Jim Cramer senses some major market controversy and calls for investors to prepare for the market to hit lower levels.
Jim Cramer sits down with Cigna CEO David Cordani to hear the story behind Cigna buying pharmacy benefits manager Express Scripts.
Canadian marijuana producer Cronos Group announced a cross-border partnership with California-based cannabis retailer MedMen on Monday, sending shares skyrocketing.
President Donald Trump said he's considering suing drugmakers for their role in fueling the opioid epidemic, sending pharma stocks tumbling.
President Trump's new plan to fight the opioid crisis includes support for a vaccine against addiction, a search that had a major breakthrough in December.
The "extraordinary" performance of growth stocks over the past year doesn't mean those names are slowing down anytime soon, according to Goldman Sachs.
President Donald Trump will unveil a plan on Monday to combat the opioid addiction crisis that includes seeking the death penalty for drug dealers and tougher enforcement laws.
President Trump's approval might have inched up, but the Democrats have a 10-lead over Republicans when it comes to Congressional preference.
Wylie is the co-founder of Cambridge Analytica, a firm he claims misused data illicitly obtained from Facebook users.
The Whole30 diet is gaining popularity among techies, who say that cutting out sugar and dairy gives them more energy.
Martin Shkreli was sentenced to seven years in prison for securities fraud charges related to a drug company he founded and two hedge funds he had run.
The death penalty for drug dealers isn't going to stop opiates from killing people, and it isn't going to take the drugs off the streets, so why is the White House so adamant about this form of punishment? Vox reports.
Get the best of CNBC in your inbox